Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity Assessment of Pentacel™ (Hybrid CP20/20/5/3DT-mIPV//PRP-T) When Given at Different Times From or Concurrently With a Pneumococcal Conjugate Vaccine

NCT00772928 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00772928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00772928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity Assessment of Pentacel™ (Hybrid CP20/20/5/3DT-mIPV//PRP-T) When Given at Different Times From or Concurrently With a Pneumococcal Conjugate Vaccine
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
November 30, 2006
Enrollment
1,167 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

diphtheria, haemophilus infection, pertussis, polio, tetanus